Reviews in Endocrine and Metabolic Disorders

, Volume 3, Issue 3, pp 243–256

Hormonal Replacement Therapy


DOI: 10.1023/A:1020028510797

Cite this article as:
Sitruk-Ware, R. Rev Endocr Metab Disord (2002) 3: 243. doi:10.1023/A:1020028510797
estrogen progestrins cardiovascular risk breast cancer risk cognition bone endometrial disease 

Copyright information

© Kluwer Academic Publishers 2002

Authors and Affiliations

  1. 1.Rockefeller University and Population CouncilNew YorkUSA

Personalised recommendations